Bio-Techne Corporation (TECH) News
Track canonical SquawkNews coverage tagged to TECH, Bio-Techne Corporation. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 29 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Techstep Awarded Contract In Sweden
Techstep ASA OSL:TECH
NEWS | Sep 25, 2026, 07:42 AM UTC
L
Bio-Techne Continues to Expect Transaction to Close by Late 2026 or Early 2027 >TECH
Bio-Techne Continues to Expect Transaction to Close by Late 2026 or Early 2027 >TECH
NEWS | Sep 23, 2026, 01:22 PM UTC
L
Bio-Techne: Waiting Period Under Hart-Scott-Rodino Antitrust Act Expired >TECH
Bio-Techne: Waiting Period Under Hart-Scott-Rodino Antitrust Act Expired >TECH
NEWS | Sep 23, 2026, 01:21 PM UTC
H
Bio-Techne Corporation (TECH) Holders Approve Acquisition by Merck KGaA
Bio-Techne shareholders approved the Merger Agreement for its acquisition by Merck KGaA, Darmstadt, Germany. HSR waiting period expired Sept. 18, 2026; closing expected by late 2026 or early 2027, subject to remaining re
MNA | Sep 23, 2026, 01:21 PM UTC
L
Bio-Techne Hldrs Approve Acquisition by Merck KGaA, Darmstadt, Germany
Bio-Techne Hldrs Approve Acquisition by Merck KGaA, Darmstadt, Germany
MNA | Sep 23, 2026, 01:20 PM UTC
L
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
MINNEAPOLIS, Sept. 23, 2026 // -- Bio-Techne Corporation (NASDAQ:TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve an
MNA | Sep 23, 2026, 01:20 PM UTC
L
TECH - Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
TECH - Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
MNA | Sep 23, 2026, 01:20 PM UTC
L
TECH - Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
TECH - Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
NEWS | Sep 22, 2026, 01:03 PM UTC
L
Bio-Techne supplements proxy disclosures after shareholder suit, seeks shareholder vote on Sept. 23
Bio-Techne supplemented its proxy statement and disclosed litigation and demand letters tied to the Merck KGaA acquisition while preserving the Sept. 23 shareholder vote.Key Highlights:Original SEC Filing: BIO-TECHNE Cor
MNA | Sep 14, 2026, 09:14 PM UTC
L
Bio-Techne achieves Science Based Targets validation
Bio-Techne achieved Science Based Targets validation and reported progress toward climate goals.
EQUITY | Sep 01, 2026, 10:30 AM UTC
L
Bio-Techne validates science-based targets and cites climate progress
Bio-Techne (TECH) announced validation of its science-based targets and reported significant progress toward its climate goals in its Fiscal 2026 highlights.
EQUITY | Sep 01, 2026, 10:30 AM UTC
L
Techstep unit recommended as sole supplier in procurement process
Techstep ASA unit has been recommended for award as the sole supplier in a procurement process.
EQUITY | Sep 01, 2026, 10:26 AM UTC
L
Techstep appoints Håvard Haukdal as permanent CFO
Techstep has appointed Håvard Haukdal as its permanent CFO.
EQUITY | Sep 01, 2026, 05:01 AM UTC
H
Nvidia-led earnings lift US tech indices, S&P 500 and Nasdaq 100 up
US equity indices gained traction on Thursday as Nvidia surged after strong results and a 70% revenue forecast next fiscal year. S&P 500 and Nasdaq 100 rose nearly 1%; Dow added 200 points, while Broadcom and Intel climb
EARNINGS | Aug 27, 2026, 05:01 PM UTC
L
TECH - Bio-Techne Corrects Dividend Announcement
TECH - Bio-Techne Corrects Dividend Announcement
EQUITY | Aug 13, 2026, 10:30 AM UTC
M
Bio-Techne Releases Q4 Fiscal 2026 Results
Bio-Techne releases fourth quarter fiscal 2026 results
EQUITY | Aug 12, 2026, 10:31 AM UTC
L
TECH - Bio-Techne Declares Dividend
TECH - Bio-Techne Declares Dividend
EQUITY | Aug 12, 2026, 10:30 AM UTC
H
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Qiagen NV (NYSE: QGEN ) is drawing renewed investor attention after reports that several private equity firms are evaluating a potential takeover of the molecular diagnostics company. The stock surged 10.5% in the previo
MACRO | Jul 10, 2026, 01:26 PM UTC
L
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold and raises the price target from $65 to $73.
EQUITY | Jun 30, 2026, 01:38 PM UTC
L
Benchmark Downgrades Bio-Techne to Hold
Benchmark analyst Robert Wasserman downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold.
EQUITY | Jun 30, 2026, 01:18 PM UTC
H
Bio-Techne, Merck KGaA Set Termination Fees
Bio-Techne to pay $230.5M termination fee to Merck KGaA if deal isn't consummated, while Merck KGaA to pay $576.1M if deal is terminated
EQUITY | Jun 26, 2026, 10:12 AM UTC
M
12 Health Care Stocks Move
Multiple health care stocks are moving in Thursday's intraday session, with gainers including Atlantic International and SELLAS Life Sciences, and losers including Nano X Imaging and Passage Bio
EQUITY | Jun 25, 2026, 05:05 PM UTC
H
Merck Buys Bio-Techne
Merck KGaA agrees to acquire Bio-Techne Corporation in an all-cash transaction valued at approximately $11.3 billion
EQUITY | Jun 25, 2026, 01:34 PM UTC
H
US Stocks: Premarket Movers
US stocks are moving premarket, with WYY up 45% and TECH up 19% on acquisition news, while ELME falls 28% on terminated agreement
EQUITY | Jun 25, 2026, 12:53 PM UTC
H
TECH Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
EQUITY | Jun 25, 2026, 12:04 PM UTC
H
Merck KGaA Acquires Bio-Techne
Merck KGaA to acquire Bio-Techne for $73 per share in cash, representing a total enterprise value of approximately $11.3 billion
EQUITY | Jun 25, 2026, 10:21 AM UTC
H
Merck Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
EQUITY | Jun 25, 2026, 10:11 AM UTC